Guest Post: Dr. Sacks, Ocular Melanoma and Gratitude
November 12, 2015Ocular melanoma survivor Anne Marie Montijo reflects on the passing of Dr. Oliver Sacks and her own goal to live each day with a spirit of gratitude. When Dr. Oliver Sacks died earlier this year from metastatic ocular melanoma (OM), I reflected on his …
FDA Approves New Targeted Therapy Combination (Vemurafenib and Cobimetinib) to Treat Advanced Melanoma
November 10, 2015Today, the FDA approved the targeted therapy combination of vemurafenib (Zelboraf®) with cobimetinib (Cotellic) for people who have advanced or metastatic melanoma and who test positive for the genetic mutation, BRAF V600. Statement from Tim Turnham, E …
Washington, D.C. Community Combats Melanoma at 7th Annual Wings of Hope Gala
November 6, 2015Washington, D.C. – On Saturday, November 7th, the Washington, D.C. melanoma community will come together to honor those who have been impacted by melanoma and raise funds to support the search for new and better treatment options at the 7th annual DC W …
#CUREOM Unite! – Thank You!
October 30, 2015The results are in and #CUREOM Unite! was a tremendous success! Thank you to everyone who gave so generously to this campaign to further patient-centered ocular melanoma (OM) research! Dear Friends, As of October 15, 2015, the #CUREOM Unite! cam …
FDA Approves First New Adjuvant Treatment for Stage III Melanoma Patients in 20 Years
October 27, 2015Statement from Tim Turnham, Executive Director, Melanoma Research Foundation Washington, D.C.—Today the Food and Drug Administration (FDA) approved ipilimumab (Yervoy) for use as a way to lower the risk of recurrence for melanoma patients …
Recent Comments